NCT00002148已完成1 期
Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 5
研究概览
简要总结
To assess the tolerability and safety of OPC-14117. To evaluate effects of OPC-14117 on cognitive function, quality of life, and activities of daily living.
详细描述
Patients receive OPC-14117 or placebo bid for 12 weeks, followed by 12 weeks of open label therapy.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (5)
Loading locations...
相似试验
已完成
3 期
A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)Edema, CardiacNCT00462670Otsuka Pharmaceutical Co., Ltd.110
终止
1 期
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple MyelomaMultiple Myeloma (MM)NCT04649073Otsuka Pharmaceutical Co., Ltd.11
已完成
2 期
A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationChronic Renal FailureNCT02331680Otsuka Pharmaceutical Co., Ltd.124
已完成
2 期
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.Alzheimers DiseaseDementiaAlzheimers Disease, FamilialNCT04623242Washington University School of Medicine194
终止
2 期
Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive TuberculosisTuberculosisNCT01131351Otsuka Pharmaceutical Development & Commercialization, Inc.10